Objectives To evaluate structure, documentation, treatment quality of a new implemented standardised insulin chart in adult medical inpatient wards at a university hospital. Design A before–after ...

Management during hospitalization was extremely complicated, leading to significant staggering of the insulin doses until the liver transplant, which allowed complete normalization of the glycemic ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

Among 35 adults using technosphere insulin in the INHALE-3 trial, 74% increased their daily dose by more than 4 U at 30 weeks. Total daily inhaled insulin dose increased from 36 U at 4 days to 52 ...

The second-largest insulin brand also comes from Novo Nordisk’s portfolio, Ryzodeg, with a MAT of Rs 593 crore, followed by Sanofi’s Lantus. Why is human insulin ... sugar control and greater ...